A listing of Darien, Connecticut clinical trials actively recruiting patient volunteers.
A Phase 4 study to evaluate Qudexy XR for the prevention of migraine in children 6 to 11 years of age.
The main aim is to see how DONQ52 works to improve small intestinal damage and reduce celiac-related symptoms due to gluten exposure, in participants with celiac disease (CeD) attempting to maintain a gluten-free diet (GFD) in treated participants versus placebo controls.
This is a double-blind, randomized, placebo-controlled Phase 2 mechanistic clinical trial designed to evaluate the therapeutic neural mechanisms of psilocybin in patients with alcohol use disorder (AUD), and to determine whether further studies are warranted to study the relationship of any such effects to clinical improvement in AUD symptoms. The …
Congrats! You have your own personal workspace now.